From the laboratory to the skin: translational potential of nanofibers in the treatment of cutaneous leishmaniasis − an overview and systematic approach
European Journal of Pharmaceutics and Biopharmaceutics · 2026
DOI: 10.1016/j.ejpb.2026.115191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von João Vitor Vicente-da-Silva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Inovação Farmacêutica e Tecnológica, Instituto Biomédico, Universidade Federal do Estado do Rio de Janeiro, RJ, Brazil; Programa de Pó…. Hauptthemen laut MEDLINE: Nanofibers, Leishmaniasis, Cutaneous, Antiprotozoal Agents. Die Arbeit nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State, Federal University of the State of Rio de Janeiro, Federal University of Rio de Janeiro.
Abstract (Originalsprache)
Cutaneous leishmaniasis (CL) remains a major global health challenge, particularly in low- and middle-income countries, due to the limitations of current therapies, including toxicity, high cost, invasive administration routes, and poor patient adherence. In this context, nanotechnology-based drug delivery systems, such as nanofibers, have emerged as promising alternatives to improve therapeutic outcomes. This study provides a comprehensive overview of CL, its epidemiology, clinical manifestations, and current pharmacological treatments, followed by a systematic and critical analysis of nanofiber-based platforms for its treatment. A structured search was conducted in PubMed, Web of Science, and Scopus databases, covering studies published between 2010 and 2026. Seventeen studies met the inclusion criteria and were analyzed in terms of polymer composition, fabrication techniques, physicochemical properties, and biological performance. The results demonstrated that polymeric nanofibers, particularly those produced by electrospinning and solution blow spinning, exhibit favorable characteristics, including high surface area, controlled drug release, biocompatibility, and enhanced local drug retention. Both in vitro and in vivo studies revealed significant antileishmanial activity, reduced cytotoxicity, and improved wound healing. Additionally, preliminary clinical findings highlighted their potential as safe and non-invasive therapeutic alternatives. Complementary bibliometric and patent analyses indicated increasing scientific and technological interest in this field, while highlighting key translational challenges related to standardization, scalability, regulatory approval, and clinical validation. Overall, nanofiber-based systems represent a promising translational strategy for the topical treatment of CL, offering advantages over conventional therapies and addressing key challenges associated with current clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Inovação Farmacêutica e Tecnológica, Instituto Biomédico, Universidade Federal do Estado do Rio de Janeiro, RJ, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universi…
- Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, RJ, Brazil; Laboratório de Tecnologia Industrial Farmacêutica, Departamento de Fármacos e Medicamentos,…
- Laboratório de Tecnologia Industrial Farmacêutica, Departamento de Fármacos e Medicamentos, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, RJ, Brazil; Departamento de Ciências Farmacêuticas, Universidade…
- Laboratório de Inovação Farmacêutica e Tecnológica, Instituto Biomédico, Universidade Federal do Estado do Rio de Janeiro, RJ, Brazil; Programa de Pós-Graduação em Biologia Molecular e Celular, Instituto Biomédico, Univ…
Förderung
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State
- Federal University of the State of Rio de Janeiro
- Federal University of Rio de Janeiro
- Coordination for the improvement of Higher Education Personnel
Zitieren
APA
Vicente-da-Silva, J. V., Calheiros-Filha, Q. N. F., Afonso, M. S., Suzuki, É. Y., Cabral, L. M., Patricio, B. F. C., & do Carmo, F. A. (2026). From the laboratory to the skin: translational potential of nanofibers in the treatment of cutaneous leishmaniasis − an overview and systematic approach. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115191
Vancouver
Vicente-da-Silva JV, Calheiros-Filha QNF, Afonso MS, Suzuki ÉY, Cabral LM, Patricio BFC, et al. From the laboratory to the skin: translational potential of nanofibers in the treatment of cutaneous leishmaniasis − an overview and systematic approach. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115191
BibTeX
@article{VicentedaSilva2026,
author = {Vicente-da-Silva, João Vitor and Calheiros-Filha, Querem Nogueira Ferreira and Afonso, Millena de Sousa and Suzuki, Érika Yoko and Cabral, Lucio Mendes and Patricio, Beatriz Ferreira de Carvalho and do Carmo, Flávia Almada},
title = {From the laboratory to the skin: translational potential of nanofibers in the treatment of cutaneous leishmaniasis − an overview and systematic approach},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2026},
doi = {10.1016/j.ejpb.2026.115191}
}
EUVIMED